Related Experiment Videos

Fibrinolytic activity of purified Serratia marcescens metalloproteases

Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
|August 1, 1985
PubMed

Insights

Two metalloproteases from Serratia marcescens showed fibrinolytic activity, degrading human fibrin and fibrinogen in plasma and commercial preparations. These enzymes offer potential for therapeutic applications targeting blood clots.

Area of Science:

  • Microbiology
  • Biochemistry
  • Enzymology

Background:

  • Serratia marcescens is a bacterium known to produce various enzymes.
  • Metalloproteases are a class of enzymes requiring metal ions for activity.
  • Fibrinolysis is the process of breaking down blood clots.

Purpose of the Study:

  • To investigate the fibrinolytic potential of purified metalloproteases from Serratia marcescens.
  • To determine if these enzymes can degrade human fibrin and fibrinogen.

Main Methods:

  • Purification of two metalloproteases from Serratia marcescens.
  • Assay of enzyme activity using human fibrin in agar plates.
  • Degradation studies using commercial human fibrinogen and fibrinogen in fresh human plasma.

Main Results:

  • Both purified Serratia marcescens metalloproteases exhibited significant fibrinolytic activity.
  • The enzymes successfully degraded human fibrin in agar.
  • Degradation of both commercial human fibrinogen and fibrinogen present in fresh human plasma was observed.

Conclusions:

  • Purified metalloproteases from Serratia marcescens possess potent fibrinolytic properties.
  • These enzymes effectively break down key components of the blood coagulation system.
  • Serratia marcescens metalloproteases represent promising candidates for developing novel fibrinolytic agents.

Related Concept Videos